Oncotelic Therapeutics Price on December 31, 2023

OTLCDelisted Stock  USD 0.02  0  6.38%   
If you're considering investing in Oncotelic OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Oncotelic Therapeutics stands at 0.02, as last reported on the 29th of November, with the highest price reaching 0.02 and the lowest price hitting 0.02 during the day. We have found twenty-three technical indicators for Oncotelic Therapeutics, which you can use to evaluate the volatility of the company. Please check Oncotelic Therapeutics' insignificant Risk Adjusted Performance, coefficient of variation of (5,652), and Variance of 203.7 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Oncotelic OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
OTLC
Based on monthly moving average Oncotelic Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncotelic Therapeutics by adding Oncotelic Therapeutics to a well-diversified portfolio.

Oncotelic Therapeutics Valuation on December 31, 2023

It is possible to determine the worth of Oncotelic Therapeutics on a given historical date. On December 31, 2023 Oncotelic was worth 0.0235 at the beginning of the trading date compared to the closed value of 0.022. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncotelic Therapeutics otc stock. Still, in general, we apply an absolute valuation method to find Oncotelic Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncotelic Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncotelic Therapeutics' related companies.
 Open High Low Close Volume
  0.02    0.02    0.02    0.02    20,100  
07/24/2023
  0.02    0.02    0.02    0.02    42,885  
  0.02    0.02    0.02    0.02    0.00  
Backtest Oncotelic Therapeutics  |  Oncotelic Therapeutics History  |  Oncotelic Therapeutics Valuation   PreviousNext  
Open Value
0.0235
0.022
Closing Value
0.02
Upside

Oncotelic Therapeutics Trading Date Momentum on December 31, 2023

On November 29 2024 Oncotelic Therapeutics was traded for  0.02  at the closing time. The top price for the day was 0.02  and the lowest listed price was  0.02 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 6.82% .

Oncotelic Therapeutics Fundamentals Correlations and Trends

By evaluating Oncotelic Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncotelic Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncotelic financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Oncotelic Therapeutics OTC Stock history

Oncotelic Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncotelic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncotelic Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncotelic Therapeutics stock prices may prove useful in developing a viable investing in Oncotelic Therapeutics
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes and CA4P for the treatment of advanced metastatic melanoma. Oncotelic Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people.

Oncotelic Therapeutics OTC Stock Technical Analysis

Oncotelic Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Oncotelic Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Oncotelic Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Oncotelic Therapeutics Period Price Range

Low
November 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Oncotelic Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Oncotelic Therapeutics November 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Oncotelic Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncotelic Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncotelic Therapeutics otc stock market strength indicators, traders can identify Oncotelic Therapeutics entry and exit signals to maximize returns

Oncotelic Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Oncotelic Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Oncotelic OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncotelic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Oncotelic OTC Stock

If you are still planning to invest in Oncotelic Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncotelic Therapeutics' history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals